CTCL Vaccines

Paris - One of the most promising areas of research for treatment of cutaneous T-cell lymphoma is the development of therapeutic vaccines, according to Wolfram Sterry, M.D., who presented an overview of vaccination therapies for treatment of CTCL here at the World Congress of Dermatology.

Related Videos
Related Content

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.